400 related articles for article (PubMed ID: 3859121)
21. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
[TBL] [Abstract][Full Text] [Related]
22. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural histochemistry of mesotheliomas and adenocarcinomas in malignant effusions.
Barsotti P; Muda AO; Ascoli V; Casareale P; Nardi F
Diagn Cytopathol; 1989; 5(2):154-61. PubMed ID: 2776597
[TBL] [Abstract][Full Text] [Related]
24. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
25. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
26. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
28. The cytopathology of mesothelioma.
Tao LC
Acta Cytol; 1979; 23(3):209-13. PubMed ID: 294056
[TBL] [Abstract][Full Text] [Related]
29. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis.
Stevens MW; Leong AS; Fazzalari NL; Dowling KD; Henderson DW
Diagn Cytopathol; 1992; 8(4):333-41. PubMed ID: 1638933
[TBL] [Abstract][Full Text] [Related]
30. Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions.
Croonen AM; van der Valk P; Herman CJ; Lindeman J
Lab Invest; 1988 Jun; 58(6):725-32. PubMed ID: 3288807
[TBL] [Abstract][Full Text] [Related]
31. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
Spieler P; Gloor F
Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
[TBL] [Abstract][Full Text] [Related]
32. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
Marsan C; Gaulier A; Sabatier P; Garcia R
Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
[TBL] [Abstract][Full Text] [Related]
33. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
Dardick I; Butler EB; Dardick AM
Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
[TBL] [Abstract][Full Text] [Related]
34. The ultrastructure of metastatic adenocarcinoma in serous fluids. An aid in identification of the primary site of the neoplasm.
Hanna W; Kahn HJ
Acta Cytol; 1985; 29(3):202-10. PubMed ID: 3859120
[TBL] [Abstract][Full Text] [Related]
35. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
Yang GC
Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
[TBL] [Abstract][Full Text] [Related]
36. Cell aggregates in malignant mesothelioma.
Whitaker D
Acta Cytol; 1977; 21(2):236-9. PubMed ID: 266334
[TBL] [Abstract][Full Text] [Related]
37. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study.
García-Bonafé M; Moragas A
Anal Cell Pathol; 1996 Nov; 12(2):85-98. PubMed ID: 8986293
[TBL] [Abstract][Full Text] [Related]
39. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
Mezger J; Lamerz R; Permanetter W
J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
